Mounjaro Injection, Solution
Product Images NDC 50090-8026

Product Visual Gallery

This gallery contains 64 technical images submitted to the FDA as part of the official labeling for Mounjaro (NDC 50090-8026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500908026)

MOUNJARO 15 mg/0.5 mL injection solution for subcutaneous use, containing tirzepatide. The label shows a 4 mL prefilled pen with 15 mg of tirzepatide per dose, distributed by A-S Medication Solutions, Libertyville, Illinois. It includes storage instructions to keep the product at 36 degrees Fahrenheit and to protect from light, with a reference to the package insert for dosing and medication guide.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Moun Pen Ifu 1 V3)

MOUNJARO 15 mg/0.5 mL injection solution in a prefilled subcutaneous syringe. The pen features a transparent cap over the needle end, a white barrel with a gray dose display window, and a purple dose selector knob at the opposite end. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Moun Pen Ifu 10 V2)

An illustration showing a close-up of a syringe tip with a labeled gray plunger inside the needle hub area, likely part of an instructional diagram related to injection technique or device components for MOUNJARO injection solution.*

FDA Label Image

Figure (Moun Pen Ifu 2 V2)

An illustrated diagram of the MOUNJARO (tirzepatide) injection pen showing labeled parts including the purple injection button, lock ring, indicator, lock or unlock symbol, medicine reservoir, clear base, and gray base cap, oriented from top (injection button) to bottom (needle end).*

FDA Label Image

Figure (Moun Pen Ifu 3 V2)

An instructional illustration of an injection pen device showing a close-up of the expiration date window on the pen. The image highlights the location of the expiration date on the pen's body with an arrow and label for easy identification.*

FDA Label Image

Figure (Moun Pen Ifu 4a V1)

An illustration showing recommended injection sites for subcutaneous administration of medication. Highlighted areas include the abdomen around the navel and the front and outer sides of the upper thighs, indicating appropriate locations for injection placement.*

FDA Label Image

Figure (Moun Pen Ifu 4b V1)

An anatomical illustration showing a rear view of a human figure highlighting two injection sites on the outer upper arms, indicated in purple. The image demonstrates potential subcutaneous injection locations.*

FDA Label Image

Figure (Moun Pen Ifu 5 V2)

An instructional illustration showing the proper removal of the gray base cap from the clear base of a MOUNJARO (tirzepatide) 15 mg/.5 mL injection pen. The image highlights the gray base cap being pulled downward and away from the clear base of the pen, with a lock icon indicating a locked position on the pen.*

FDA Label Image

Figure (Moun Pen Ifu 6 V2)

An instructional illustration showing a person administering a subcutaneous injection in the abdominal area. The image depicts the proper hand positioning and angle for injecting the medication using a pen device.*

FDA Label Image

Figure (Moun Pen Ifu 7 V2)

An instructional illustration showing a hand holding a MOUNJARO injection pen. The image highlights the mechanism of unlocking or preparing the pen for use, with an arrow indicating rotation and a zoomed-in view of a lock symbol on the pen cap.*

FDA Label Image

Figure (Moun Pen Ifu 8 V2)

An instructional illustration showing a person holding a MOUNJARO injection pen close to the abdomen, demonstrating the proper technique for administering a subcutaneous injection.*

FDA Label Image

Figure (Moun Pen Ifu 9 V2)

A close-up diagram showing the gray plunger inside a clear cap or container component, with a red arrow and label pointing to the gray plunger.*

FDA Label Image

Figure (Moun Qr)

FDA Label Image

Structural Formula (Moun Uspi Chem Struc)

Chemical structure diagram of the active ingredient tirzepatide, showing its peptide sequence with amino acid abbreviations and chemical bonds.*

FDA Label Image

Figure 1 (Moun Uspi F1 V1)

A line graph displaying insulin levels (mIU/L) over time (minutes) with two phases indicated. Four lines represent placebo baseline, placebo week 28, tirzepatide 15 mg baseline, and tirzepatide 15 mg week 28, showing higher insulin levels over time for tirzepatide at week 28 compared to placebo and baseline measurements.*

FDA Label Image

Figure 2 (Moun Uspi F2 V1)

A line graph comparing HbA1c (%) levels over weeks post-randomization for MOUNJARO injection at doses of 5 mg, 10 mg, and 15 mg, alongside Semaglutide 1 mg. The x-axis displays weeks post-randomization up to 40, and the y-axis shows HbA1c percentage ranging from 5.5 to 8.5. The graph illustrates HbA1c reduction trends for each treatment over time.*

FDA Label Image

Figure (Moun Vial Ifu 1 V1)

An illustration of a MOUNJARO (tirzepatide injection) vial showing the protective cap on top, with a note indicating a rubber stopper located underneath the cap.*

FDA Label Image

Figure (Moun Vial Ifu 10 V1)

An instructional illustration showing a person holding a vial and drawing up medication into a syringe. The image depicts the technique of withdrawing a solution from a vial for injection preparation.*

FDA Label Image

Figure (Moun Vial Ifu 11 V1)

Illustration showing a person drawing medication from a vial into a syringe, demonstrating a step in preparing an injectable solution for subcutaneous administration.*

FDA Label Image

Figure (Moun Vial Ifu 12 V1)

An instructional illustration showing a hand holding a syringe for a subcutaneous injection into the forearm, with a zoomed inset of the syringe barrel displaying graduated volume markings from 0.0 to 0.5 mL. A downward arrow indicates the direction of injection.*

FDA Label Image

Figure (Moun Vial Ifu 13 V1)

An instructional illustration showing two hands preparing an injection. One hand holds a vial upside down, with a syringe attached drawing the solution, while the other hand stabilizes the vial, suggesting the preparation of a subcutaneous injection solution such as MOUNJARO (tirzepatide) 15 mg/.5mL.*

FDA Label Image

Figure (Moun Vial Ifu 14 V1)

An instructional illustration showing a person holding a vial and using a syringe to draw liquid from the vial. A close-up inset focuses on the syringe barrel, indicating volume markings from 0.1 to 0.5 mL. The image demonstrates how to draw up 0.5 mL of solution, consistent with the 15 mg/.5 mL dosage form of the MOUNJARO injection.*

FDA Label Image

Figure (Moun Vial Ifu 15 V1)

An instructional illustration showing a person holding a vial in one hand and drawing medication into a syringe held in the other hand, with an arrow indicating the direction of syringe movement.*

FDA Label Image

Figure (Moun Vial Ifu 16 V1)

An anatomical illustration highlighting recommended subcutaneous injection sites for MOUNJARO (tirzepatide) injection. Shaded areas indicate the abdomen around the navel and the front and outer portions of the thighs as appropriate injection locations.*

FDA Label Image

Figure (Moun Vial Ifu 17 V1)

An anatomical illustration showing the human back and arms with shaded areas on the upper arms, indicating recommended injection sites for subcutaneous administration.*

FDA Label Image

Figure (Moun Vial Ifu 18 V1)

An instructional illustration showing a person preparing to administer a subcutaneous injection into the abdominal area. The image focuses on a hand holding a syringe and the exposed abdomen of a person, indicating the injection site.*

FDA Label Image

Figure (Moun Vial Ifu 19 V1)

An instructional illustration showing the administration of an injection into the abdominal area. The image depicts a hand holding a syringe, preparing to inject subcutaneously around the navel, with an arrow indicating the injection direction.*

FDA Label Image

Figure (Moun Vial Ifu 2 V1)

Diagram of a syringe showing detailed parts including the needle shield, needle, plunger tip, plunger, and syringe body. A magnified section highlights the syringe body markings between 0.4 and 0.6 mL.*

FDA Label Image

Figure (Moun Vial Ifu 20 V1)

An instructional line drawing showing a hand holding a syringe for a subcutaneous injection into the neck area of a person. An arrow points outward from the syringe needle, indicating the injection angle or direction.*

FDA Label Image

Figure (Moun Vial Ifu 3 V1)

An instructional black-and-white illustration showing a hand removing the cap from a small vial or bottle, likely demonstrating preparation for injection.*

FDA Label Image

Figure (Moun Vial Ifu 4 V1)

An instructional illustration showing two hands holding a vial while peeling back or removing the cap or seal from the vial top. This likely demonstrates preparation steps for an injectable medication, such as MOUNJARO (tirzepatide) 15 mg/.5 mL solution for subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 5 V1)

An instructional illustration depicting the technique for holding a folded skin fold with one hand while using the other hand to insert a syringe needle into the skin for subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 6 V1)

An instructional illustration showing a person holding an injection device with one hand and peeling back a protective covering or adhesive backing with the other hand. The image demonstrates preparation steps for using an injection product, likely intended for subcutaneous administration.*

FDA Label Image

Figure (Moun Vial Ifu 7 V1)

An instructional diagram showing a twisting or turning motion, likely indicating how to manipulate or use a component of a medical device or injection pen.*

FDA Label Image

Figure (Moun Vial Ifu 8 V1)

An instructional illustration showing two hands holding a syringe with an arrow pointing to the left, indicating a step in syringe preparation or use.*

FDA Label Image

Figure (Moun Vial Ifu 9 V1)

An instructional illustration showing hands preparing a syringe injection with a downward arrow indicating the plunger being pushed. There is a close-up inset of the syringe barrel marked with volume measurements from 0.1 to 0.5 mL, emphasizing proper dosage measurement.*

FDA Label Image

Figure (Moun Vial Md Ifu 14 V1)

An instructional illustration showing hands drawing liquid from a vial into a syringe. An inset close-up shows the syringe barrel with measurement markings from 0.1 to 0.6 mL, highlighting a dose near 0.6 mL. The image includes an upward arrow indicating the direction of liquid withdrawal.*

FDA Label Image

Figure (Moun Vial Md Ifu 2 V1)

Diagram of a syringe assembly showing a needle shield, needle, syringe body with volume markings from 0 to 1 mL, and a plunger with plunger tip. A zoomed inset highlights the 0.5 mL marking on the syringe body. The illustration is labeled to identify each part precisely.*

FDA Label Image

Figure (Moun Vial Md Ifu 9 V1)

An instructional illustration showing a hand holding a syringe with a needle pointing downward. An inset detail displays a close-up of the syringe barrel with measurement markings from 0.1 to 0.6 mL, focusing on the liquid level near 0.6 mL. The image appears to demonstrate the proper handling or measurement of injection solution volume.*

FDA Label Image

Figure (Mounjaro Kp 1 Pen V1)

MOUNJARO 15 mg/0.5 mL injection pen for subcutaneous use. The image shows a dose-measuring injection pen with a white body, a gray clip, a dose window displaying the number '0', and a purple cap. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Mounjaro Kp 10 Dial Clicks V1)

An instructional illustration showing a hand peeling or lifting a tab or seal from a container or device, indicated by a red curved arrow pointing downward toward the tab.*

FDA Label Image

Figure (Mounjaro Kp 11 Dial Zoom V1)

MOUNJARO 15 mg/0.5 mL injection solution in a subcutaneous prefilled syringe, presented in the packaging labeled with tirzepatide as the active ingredient. The label displays the product name, strength, dosage form, route of administration, labeler A-S Medication Solutions, and the NDC 50090-8026 prominently on the carton.*

FDA Label Image

Figure (Mounjaro Kp 12 Tap V1)

An instructional illustration showing a hand holding a syringe injection pen with the other hand pressing the injection button, indicated by a red arrow pointing outward to show the injection action.*

FDA Label Image

Figure (Mounjaro Kp 13 5sec Hold V1)

An instructional illustration showing a hand holding a prefilled syringe with a droplet at the needle tip, accompanied by a stopwatch icon and a close-up of the syringe needle to indicate waiting or timing during injection preparation or administration.*

FDA Label Image

Figure (Mounjaro Kp 14 Zero Dial Zoom V1)

MOUNJARO 15 mg/.5 mL injection, solution for subcutaneous use, packaged in a multi-dose pen from A-S Medication Solutions. The label prominently features the proprietary name, strength, dosage form, and includes instructions for use with a pen device. The packaging is primarily white with purple and grayscale text and graphics.*

FDA Label Image

Figure (Mounjaro Kp 15 Inj Sites V1)

An anatomical illustration showing preferred injection sites for subcutaneous administration of MOUNJARO (tirzepatide) injection. Marked areas include the abdomen, front of the thighs, and outer upper arms on a human figure viewed from front and back.*

FDA Label Image

Figure (Mounjaro Kp 16 Dial 1 Dose V1)

An instructional illustration showing how to dial the dose on an injectable pen device for MOUNJARO tirzepatide injection. The diagram depicts a hand turning the dial mechanism on the pen to set the dose before use.*

FDA Label Image

Figure (Mounjaro Kp 17 Dial 1 Zoom V1)

MOUNJARO 15 mg/0.5 mL injection, solution for subcutaneous use by A-S Medication Solutions. The visible image shows a single-dose vial or cartridge packaging container with clear labeling of the proprietary name MOUNJARO and concentration 15 mg/0.5 mL.*

FDA Label Image

Figure (Mounjaro Kp 18 Insert Needle V1)

An instructional illustration showing a hand holding a subcutaneous injection pen near an abdomen. The image includes an arrow indicating the direction for injecting the medication into the abdominal area, relevant to subcutaneous administration instructions for MOUNJARO (tirzepatide) injection.*

FDA Label Image

Figure (Mounjaro Kp 19 Push Hold V1)

An instructional diagram showing the subcutaneous injection technique for MOUNJARO (tirzepatide) injection. The image depicts a hand holding the injection device pressed against skin, with an arrow indicating to push and instructions to hold for 5 seconds before removing the needle.*

FDA Label Image

Figure (Mounjaro Kp 2 Pen Parts V2)

An instructional diagram of a MOUNJARO injection pen showing labeled parts including the pen cap with clip, cartridge, cartridge holder, plunger, pen body with label, dose window and dose indicator, and dose knob. It also illustrates pen needle components (not included) such as the outer needle shield, inner needle shield, needle, and paper tab, with a close-up of the cartridge's red inner seal.*

FDA Label Image

Figure (Mounjaro Kp 20 Remove V1)

An instructional illustration showing a hand holding a prefilled injection pen, positioned for subcutaneous injection into the abdomen. An arrow points away from the injection site, indicating the direction to insert or move the device for administration.*

FDA Label Image

Figure (Mounjaro Kp 21 Cotton Ball V1)

An instructional illustration showing a person cleaning the skin, likely in preparation for an injection. A hand holds a cotton ball or swab applying it to the skin, with a red arrow pointing to the area being cleaned.*

FDA Label Image

Figure (Mounjaro Kp 22 Recap Shield V1)

An instructional illustration showing a hand holding a pen-style injection device with the protective cap being removed, indicated by a red arrow. The image demonstrates preparation steps for subcutaneous injection delivery.*

FDA Label Image

Figure (Mounjaro Kp 23 Remove Needle V1)

An instructional illustration showing a hand holding a protective cap being removed from the end of a pen injector device, with a red arrow indicating the direction of removal.*

FDA Label Image

Figure (Mounjaro Kp 24 Recap Pen V1)

An instructional illustration showing a pen-like injection device with its cap being removed or slid off in the direction indicated by a red arrow pointing to the left.*

FDA Label Image

Figure (Mounjaro Kp 3 Wash V1)

Illustration showing handwashing with soap bubbles, depicting a hygiene or cleaning process involving rubbing hands together with soap.*

FDA Label Image

Figure (Mounjaro Kp 4 Uncap V1)

An instructional illustration showing the removal of a cap from a pen-style injection device by pulling it off in the direction of a left-pointing red arrow. The device is likely used for subcutaneous injection of medication.*

FDA Label Image

Figure (Mounjaro Kp 5 Wipe V1)

An instructional illustration showing hands wiping the rubber stopper of a vial or pen with a cloth or alcohol swab in preparation for injection or medication withdrawal.*

FDA Label Image

Figure (Mounjaro Kp 6 New Needle Tab V1)

An instructional illustration showing a hand peeling or removing a protective cap from a small cylindrical injection device, with a red arrow indicating an upward and outward motion.*

FDA Label Image

Figure (Mounjaro Kp 7 Attach Needle V1)

An instructional illustration showing the proper method to attach or twist the needle cap on a pen injector device, with two red arrows indicating rotational movement in opposite directions on the device's tip and body.*

FDA Label Image

Figure (Mounjaro Kp 8 Outer Shield V1)

An instructional illustration showing the removal of a cap from the tip of a syringe or injection pen. The image depicts a close-up of the device with an arrow pointing upwards, indicating to pull the cap straight off before use.*

FDA Label Image

Figure (Mounjaro Kp 9 Inner Shield V1)

An instructional diagram showing a vial with its cap being pulled upward, indicating removal of the cap from the vial before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.